1. Home
  2. MNKD vs BV Comparison

MNKD vs BV Comparison

Compare MNKD & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • BV
  • Stock Information
  • Founded
  • MNKD 1991
  • BV 1939
  • Country
  • MNKD United States
  • BV United States
  • Employees
  • MNKD N/A
  • BV N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • BV Business Services
  • Sector
  • MNKD Health Care
  • BV Consumer Discretionary
  • Exchange
  • MNKD Nasdaq
  • BV Nasdaq
  • Market Cap
  • MNKD 1.8B
  • BV 1.6B
  • IPO Year
  • MNKD 2004
  • BV 2018
  • Fundamental
  • Price
  • MNKD $6.22
  • BV $16.91
  • Analyst Decision
  • MNKD Strong Buy
  • BV Buy
  • Analyst Count
  • MNKD 5
  • BV 8
  • Target Price
  • MNKD $8.40
  • BV $17.41
  • AVG Volume (30 Days)
  • MNKD 2.8M
  • BV 471.6K
  • Earning Date
  • MNKD 11-07-2024
  • BV 01-29-2025
  • Dividend Yield
  • MNKD N/A
  • BV N/A
  • EPS Growth
  • MNKD N/A
  • BV N/A
  • EPS
  • MNKD 0.08
  • BV 0.20
  • Revenue
  • MNKD $267,200,000.00
  • BV $2,767,100,000.00
  • Revenue This Year
  • MNKD $45.36
  • BV $3.86
  • Revenue Next Year
  • MNKD $16.99
  • BV $3.55
  • P/E Ratio
  • MNKD $74.80
  • BV $85.25
  • Revenue Growth
  • MNKD 51.35
  • BV N/A
  • 52 Week Low
  • MNKD $3.17
  • BV $7.75
  • 52 Week High
  • MNKD $7.63
  • BV $18.89
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 38.90
  • BV 49.63
  • Support Level
  • MNKD $5.81
  • BV $16.50
  • Resistance Level
  • MNKD $6.77
  • BV $17.16
  • Average True Range (ATR)
  • MNKD 0.25
  • BV 0.50
  • MACD
  • MNKD -0.07
  • BV -0.06
  • Stochastic Oscillator
  • MNKD 36.44
  • BV 26.58

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

Share on Social Networks: